Image: Wiki Commons
Telehealth startup Done, which prescribes ADHD medication like Adderall, is under investigation by the Drug Enforcement Administration, The Wall Street Journal reported.
The investigation is part of an ongoing crackdown on mental health companies using telemedicine to prescribe controlled substances, a category that includes stimulants like Adderall and addictive painkillers like OxyContin. The DEA is also investigating telehealth company Cerebral over its prescribing practices. That company announced it would stop prescribing drugs in that category in May.
Done told The Wall Street Journal that it hadn’t had any direct contact from the DEA and that it is committed to “complying with all applicable laws and regulations.”